Search

Oxidative leaching is an inexpensive alternative to using chemical cyanide extraction methods for gold from low-grade gold sulfide. Oxidation of finely ground gold-bearing ore by Acidithiobacillus ferrooxidans was evaluated in terms of cell density, pH, and leaching efficiency of Fe and Au in shake flask experiments. The compositional and elemental analyses of the beneficiated ore were analyzed using XRD and EDXRF spectroscopy. The ore’s primary constituents are gold (4.356 mg/L), silicon, iron, and sulfur (62.456, 15.441, and 7.912 wt%, respectively). XRD spectra, the main phases of the concentrated ore, showed that the major components of the ore were quartz, syn, silicon sulfide, pyrite, and polymetallic elements such as silderenrite, gismondine, siderenikite, hematite, and syn. The experimental results, with Acidithiobacillus ferrooxidans bacteria and blank, were evaluated. The pH of the blank remained nearly constant, and the pH of the bioleached was occasionally lowered. The A. ferrooxidans strain always grew better throughout the bioleaching process. For the A. ferrooxidans strain, the cell density of cells reached a maximum of 90.00 × 106 cells/mL after the 11th week and decreased to 87.00 × 106 cells/mL after the 12th week. The decrease in cell density may be due to the presence of polymetallic elements such as Al, Cr, Ti, and Ni, leading to reduced metal tolerance of the A. ferrooxidans strain. In the A. ferrooxidans leaching process, the maximum total iron and gold extraction reached 92.16% (14.23 mg/L) and 99.97% (4.355 ppm), respectively, after the 11th week, and leaching tends to decrease up to 14 weeks, which may be due to the formation of secondary minerals. More research will be performed to optimize the procedure and leaching kinetic, examine the impact of metal content, and take into account the potential for bioleaching process pollution in addition to the amount of gold recovered.

We report in this paper antibacterial activity of Ag-doped TiO2 and Ag-doped ZnO nanoparticles (NPs) under visible light irradiation synthesized by using a sol-gel method. Structural, morphological, and basic optical properties of these samples were investigated using X-ray diffraction (XRD), scanning electron microscopy (SEM), energy dispersive X-ray (EDX) spectrum, and UV-Vis reflectance. Room temperature X-ray diffraction analysis revealed that Ag-doped TiO2 has both rutile and anatase phases, but TiO2 NPs only have the anatase phase. In both ZnO and Ag-doped ZnO NPs, the hexagonal wurtzite structure was observed. The morphologies of TiO2 and ZnO were influenced by doping with Ag, as shown from the SEM images. EDX confirms that the samples are composed of Zn, Ti, Ag, and O elements. UV-Vis reflectance results show decreased band gap energy of Ag-doped TiO2 and Ag-doped ZnO NPs in comparison to that of TiO2 and ZnO. Pathogenic bacteria, such as Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, were used to assess the antibacterial activity of the synthesized materials. The reduction in the viability of all the three bacteria to zero using Ag-doped ZnO occurred at 60 μg/mL of culture, while Ag-doped TiO2 showed zero viability at 80 μg/mL. Doping of Ag on ZnO and TiO2 plays a vital role in the increased antibacterial activity performance.

In this study, a N-doped Cu2O/ZnO nanocomposite was prepared by a co-precipitation and thermal decomposition technique from CuCl2, 2H2O, ZnSO4, 7H2O and CO(NH2)2 as precursors. The as-synthesized nanocomposites were characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier transform infrared analysis (FT−IR) and an ultraviolet−visible (UV−Vis) reflectance spectrometer. From the XRD diffractogram of N-doped Cu2O/ZnO nanocomposite, cubic and hexagonal wurtzite crystal structures of Cu2O, and ZnO, respectively were identified. The UV-vis reflectance spectra illustrated that the absorption edge of N-doped Cu2O/ZnO nanocomposite is more extended to the longer wavelength than ZnO, Cu2O and Cu2O/ZnO nanomaterials. FT−IR bands confirmed the presence of ZnO, Cu2O, and nitrogen in the N-doped Cu2O/ZnO nanocomposite. Photocatalytic activity of the as-synthesized nanocomposite was tested for methyl red degradation using sunlight as an energy source by optimizing the concentration of the dye and amount of the catalyst loaded. The degradation efficiency was greater in N-doped Cu2O/ZnO nanocomposite as compared to ZnO, Cu2O and Cu2O/ZnO nanomaterials. This is due to the coupling of the semiconductors which increases the absorption and exploitation capability of solar light and increases the charge separation as well. Besides that, nitrogen doping can extend absorption of light to the visible region by decreasing the energy gap. Therefore, N-doped Cu2O/ZnO nanocomposite is a solar light-active photocatalyst which can be used in the degradation of organic pollutants.

Background: There are limited data on the performance of the use of fixed-dose combination (FDC) TB drugs when used under programmatic settings in high TB-endemic countries. We evaluated the efficacy and safety of FDC versus loose formulation (LF) TB treatment regimens for treatment of pulmonary TB (PTB) in the context of actual medical practice in prevailing conditions within programmatic settings in five sites in two high TB-burden African countries. Methods: A two-arm, single-blind, randomized clinical trial comparing FDCs with separate LFs involving 1000 adults newly diagnosed with culture positive PTB was conducted at five sites in two African countries between 2007 and 2011. Participants were randomized to receive daily treatment with anti-TB drugs given as either FDC or separate LFs for 24 weeks (intensive phase– 8 weeks of isoniazid, rifampicin, ethambutol and pyrazinamide; continuation phase– 16 weeks of rifampicin and isoniazid). Primary outcome measures were microbiological cure and safety at the end of six months’ treatment; pre-specified non-inferiority margin for difference in cure rate was 4%. The primary efficacy analysis was based on the modified intent to treat (mITT) cohort comprising all randomized patients with a positive baseline culture result for TB and who received at least one dose of study treatment. Patients missing end of treatment culture results were considered failures. Further analyses were done in which mITT patients without an end of treatment (EOT) culture were excluded in a complete case analysis (mITTcc) and a per protocol cohort analysis defined as mITTcc patients who received at least 95% of their intended doses and had an EOT culture result. Results: In the mITT analysis, the cure rate in the FDC group was 86.7% (398/459) and in the LF group 85.2% (396/465) (difference 1.5-% (90% confidence interval (CI) (-2.2%– 5.3%)). Per Protocol analysis showed similar results: FDC 98.9% (359/363) versus LF 96.9% (345/356), (difference 2.0% (90% CI: 0.1%– 3.8%)). The two arms showed no significant differences in terms of safety, early culture conversion and patient adherence to treatment. Interpretation: The comparison of the two drug regimens satisfied the pre-specified non-inferiority criterion. Our results support the WHO recommendations for the use of FDC in the context of actual medical practice within health services in high TB-endemic countries. Trial Registration: ISRCTN Registry [ABSTRACT FROM AUTHOR]